Browse studies

Find your next paid study

28 recruiting studies matching your filters

Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma

The purpose of this study is to compare how well tolerated and effective four different dosing schedules (two personalized, intermittent dosing schedules as co…

Advanced Basal Cell Carcinoma

Estimated

~$10 – $6,250

H. Lee Moffitt Cancer Center and Research InstituteNCT05651828

Phase 1

An Open-Label Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma

This study will be a multicenter, prospective, open label, one-arm study intended to assess the Safety and Efficacy of EscharEx (EX-02) in the treatment of Bas…

Superficial Basal Cell CarcinomaNodular Basal Cell Carcinoma

Estimated

~$10 – $8,750

MediWound LtdNCT05157763

Phase 1

Using Fractional Lasers and Tirbanibulin Ointment to Treat Keratinocyte Carcinomas

The investigators seek to evaluate the effectiveness of fractional laser therapy and tirbanibulin ointment to treat squamous and basal cell carcinomas. This wi…

Keratinocyte CarcinomaBasal Cell CarcinomasSquamous Cell Carcinoma+1 more

Estimated

~$10 – $7,500

Bruce Robinson, MDNCT07010692

Phase 2

Neoadjuvant REGN2810 (Cemiplimab) or REGN2810 (Cemiplimab) Plus REGN3767 (Fianlimab) in Cutaneous Basal Cell Carcinoma of the Head and Neck

A non-randomized two-cohort study of neoadjuvant Cemiplimab or neoadjuvant Cemiplimab plus Fianlimab (CF) in patients with basal cell carcinoma of the head and…

Locally Advanced Basal Cell CarcinomaBasal Cell Carcinoma

Estimated

~$10 – $6,250

Thomas Jefferson UniversityNCT05929664